Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 28, 2015 12:21 AM ET

Biotechnology

Company Overview of CytoSolv Inc.

Company Overview

CytoSolv Inc. engages in the development of a technology for the cure of diabetic ulcers. The company was founded in 2009 and is based in Tiverton, Rhode Island.

155 Pelletier Lane

Tiverton, RI 02878-3007

United States

Founded in 2009

Phone:

401-241-0429

Key Executives for CytoSolv Inc.

Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Luminex Madison United States
Rosetta Genomics Inc. United States
AngioDesign Inc. United States
Meditope Biosciences, Inc. United States
Axerion Therapeutics, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CytoSolv Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.